Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
This study represents the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations ...
Glucotrack, Inc.: Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization ...
Morningstar3d
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
The CBGM sensor lead was placed intravascularly ... This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
manilatimes4d
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
The CBGM sensor lead was placed intravascularly via a percutaneous ... This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Morningstar9d
Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer
Glucotrack’s CBGM is a long-term ... This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained ...
Mena FN18d
Glucotrack Announces ISO 13485:2016 Certification
Glucotrack's CBGM is a long-term, implantable system that continually ... Forward-Looking Statements This news release contains forward-looking statements within the meaning of the Private Securities ...
Glucotrack, Inc.: Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer
Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization ...
Nasdaq9d
Glucotrack, Inc. Appoints Peter C. Wulff as Chief Financial Officer
Glucotrack’s CBGM is a long-term ... please visit This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs
“I am honored to join the Company at this pivotal time as we advance our human clinical trials and create a strategic regulatory program for the Continuous Blood Glucose Monitor (CBGM),” said Mr.